Ethics, Policy & Law
Innovation, risk, and patient empowerment: The FDA-mandated withdrawal of 23andMe's personal genome service
Downing N, et al. JAMA. 2014;311(8):793-794.
Downing N, et al. JAMA. 2014;311(8):793-794.
Oocyte modification in assisted reproduction for the prevention of transmission of mitochondrial disease or treatment of infertility, 
[PDF 182.43 KB] Cellular, Tissue, and Gene Therapies Advisory Committee, FDA Briefing Document
[PDF 182.43 KB] Cellular, Tissue, and Gene Therapies Advisory Committee, FDA Briefing DocumentUS regulator considers science of mitochondrial replacement, by Dr Philippa Brice, PHG Foundation, Feb 24
by Dr Philippa Brice, PHG Foundation, Feb 24FDA weighs fertility method that raises ethical questions, The New York Times, Feb 25
The New York Times, Feb 25New technique can encrypt genetic data, protecting privacy while assisting biomedical research, by Meagan Phelan, American Association for Advancement of Science, Feb 17
by Meagan Phelan, American Association for Advancement of Science, Feb 17
.png)
No hay comentarios:
Publicar un comentario